A private equity firm based in Beijing, China specializes in growth capital and buy-out investment. The firm focuses on growing Chinese and Western companies in several sectors including healthcare that benefit from China’s growing consumption population. The firm invests north of US$20 million in companies in Series B, C, or above. The firm considers opportunities from China as well as overseas deals with a China angle.
Within healthcare, the firm is looking for cutting-edge technologies in biopharmaceuticals, medical devices, diagnostics, and technology platform. The firm typically prefers mature companies. However, the firm is also interested in pre-revenue companies with disruptive technologies that address large unmet needs.
The firm is seeking experienced management teams with strong sector knowledge. The firm may request board representation post-investment.
If you are interested in more information about this investor and other investors tracked by LSN, please email email@example.com